Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 91 of 1,261
  1. US 12102609

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  2. US 12102640

    Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  3. US 12102682

    Injectable photothermal hydrogel based on melanin, preparation method, and application thereof

    OCEAN UNIVERSITY OF CHINA · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  4. US 12102662

    Methods for storing and warming purified corticotropin compositions

    ANI Pharmaceuticals, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  5. US 12102617

    Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agent

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  6. US 12102606

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    AXSOME THERAPEUTICS, INC. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  7. WO 2024194388

    PREPARATION DE LEVURE SACCHAROMYCES BOULARDII INACTIVEE

    BIOCODEX [FR] · Granted Sep 26, 2024 · Expires Sep 21, 2044

    granted
  8. US 12097189

    Pharmaceutical composition for modified release

    ASTELLAS PHARMA INC [JP] · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  9. US 12097192

    Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator

    Corcept Therapeutics Incorporated · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  10. US 12096754

    Non-human animals having a humanized lymphocyte-activation gene 3

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  11. US 12097230

    Method and composition for treating post operative conditions

    Bright Green Corporation · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  12. US 12098152

    Methods and compositions for treating polycystic ovary syndrome

    SPRUCE BIOSCIENCES, INC. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  13. US 12097188

    Compositions and methods for the treatment of macular degeneration

    Aldeyra Therapeutics, Inc. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  14. US 12097198

    Treatment of prostate cancer

    Takeda Pharmaceutical Company Limited · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  15. US 12097210

    Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

    Corcept Therapeutics Incorporated · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  16. US 12097185

    Compositions comprising ciprofloxacin and celecoxib

    NEUROSENSE THERAPEUTICS LTD. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  17. US 12097183

    Pharmaceutical composition for treating migraine

    Tonix Medicines, Inc. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  18. US 12097291

    Thermostable vaccine compositions and methods of preparing same

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  19. US 12097219

    Single-domain antibodies against CLL1 and constructs thereof

    Legend Biotech Ireland Limited · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  20. US 12097261

    CDK2 degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  21. US 12097264

    Methods and compositions for theranostic nanoparticles

    Sanford Burnham Prebys Medical Discovery Institute at Lake Nona · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  22. US 12098182

    Polypeptides, cells, and methods involving engineered CD16

    Regents of the University of Minnesota · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  23. US 12098385

    Gene therapy strategy to restore cardiac electrical and structural function in arrhythmogenic right ventricular cardiomyopathy

    The Regents of the University of California · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  24. US 12098155

    Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

    SPERO THERAPEUTICS, INC. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.